Early Events in Japanese Encephalitis Virus Infection: Viral Entry

Japanese encephalitis virus (JEV), a mosquito-borne zoonotic flavivirus, is an enveloped positive-strand RNA virus that can cause a spectrum of clinical manifestations, ranging from mild febrile illness to severe neuroinvasive disease. Today, several killed and live vaccines are available in differe...

Full description

Bibliographic Details
Main Authors: Sang-Im Yun, Young-Min Lee
Format: Article
Language:English
Published: MDPI AG 2018-08-01
Series:Pathogens
Subjects:
Online Access:http://www.mdpi.com/2076-0817/7/3/68
_version_ 1798041954710192128
author Sang-Im Yun
Young-Min Lee
author_facet Sang-Im Yun
Young-Min Lee
author_sort Sang-Im Yun
collection DOAJ
description Japanese encephalitis virus (JEV), a mosquito-borne zoonotic flavivirus, is an enveloped positive-strand RNA virus that can cause a spectrum of clinical manifestations, ranging from mild febrile illness to severe neuroinvasive disease. Today, several killed and live vaccines are available in different parts of the globe for use in humans to prevent JEV-induced diseases, yet no antivirals are available to treat JEV-associated diseases. Despite the progress made in vaccine research and development, JEV is still a major public health problem in southern, eastern, and southeastern Asia, as well as northern Oceania, with the potential to become an emerging global pathogen. In viral replication, the entry of JEV into the cell is the first step in a cascade of complex interactions between the virus and target cells that is required for the initiation, dissemination, and maintenance of infection. Because this step determines cell/tissue tropism and pathogenesis, it is a promising target for antiviral therapy. JEV entry is mediated by the viral glycoprotein E, which binds virions to the cell surface (attachment), delivers them to endosomes (endocytosis), and catalyzes the fusion between the viral and endosomal membranes (membrane fusion), followed by the release of the viral genome into the cytoplasm (uncoating). In this multistep process, a collection of host factors are involved. In this review, we summarize the current knowledge on the viral and cellular components involved in JEV entry into host cells, with an emphasis on the initial virus-host cell interactions on the cell surface.
first_indexed 2024-04-11T22:28:46Z
format Article
id doaj.art-d106b145b5224bfb81f78e9b2e7f8971
institution Directory Open Access Journal
issn 2076-0817
language English
last_indexed 2024-04-11T22:28:46Z
publishDate 2018-08-01
publisher MDPI AG
record_format Article
series Pathogens
spelling doaj.art-d106b145b5224bfb81f78e9b2e7f89712022-12-22T03:59:34ZengMDPI AGPathogens2076-08172018-08-01736810.3390/pathogens7030068pathogens7030068Early Events in Japanese Encephalitis Virus Infection: Viral EntrySang-Im Yun0Young-Min Lee1Department of Animal, Dairy, and Veterinary Sciences, College of Agriculture and Applied Sciences, Utah State University, Logan, UT 84322, USADepartment of Animal, Dairy, and Veterinary Sciences, College of Agriculture and Applied Sciences, Utah State University, Logan, UT 84322, USAJapanese encephalitis virus (JEV), a mosquito-borne zoonotic flavivirus, is an enveloped positive-strand RNA virus that can cause a spectrum of clinical manifestations, ranging from mild febrile illness to severe neuroinvasive disease. Today, several killed and live vaccines are available in different parts of the globe for use in humans to prevent JEV-induced diseases, yet no antivirals are available to treat JEV-associated diseases. Despite the progress made in vaccine research and development, JEV is still a major public health problem in southern, eastern, and southeastern Asia, as well as northern Oceania, with the potential to become an emerging global pathogen. In viral replication, the entry of JEV into the cell is the first step in a cascade of complex interactions between the virus and target cells that is required for the initiation, dissemination, and maintenance of infection. Because this step determines cell/tissue tropism and pathogenesis, it is a promising target for antiviral therapy. JEV entry is mediated by the viral glycoprotein E, which binds virions to the cell surface (attachment), delivers them to endosomes (endocytosis), and catalyzes the fusion between the viral and endosomal membranes (membrane fusion), followed by the release of the viral genome into the cytoplasm (uncoating). In this multistep process, a collection of host factors are involved. In this review, we summarize the current knowledge on the viral and cellular components involved in JEV entry into host cells, with an emphasis on the initial virus-host cell interactions on the cell surface.http://www.mdpi.com/2076-0817/7/3/68Japanese encephalitis virusflavivirusviral replicationviral entryattachmentbindingendocytosisinternalizationmembrane fusionvirus-host interaction
spellingShingle Sang-Im Yun
Young-Min Lee
Early Events in Japanese Encephalitis Virus Infection: Viral Entry
Pathogens
Japanese encephalitis virus
flavivirus
viral replication
viral entry
attachment
binding
endocytosis
internalization
membrane fusion
virus-host interaction
title Early Events in Japanese Encephalitis Virus Infection: Viral Entry
title_full Early Events in Japanese Encephalitis Virus Infection: Viral Entry
title_fullStr Early Events in Japanese Encephalitis Virus Infection: Viral Entry
title_full_unstemmed Early Events in Japanese Encephalitis Virus Infection: Viral Entry
title_short Early Events in Japanese Encephalitis Virus Infection: Viral Entry
title_sort early events in japanese encephalitis virus infection viral entry
topic Japanese encephalitis virus
flavivirus
viral replication
viral entry
attachment
binding
endocytosis
internalization
membrane fusion
virus-host interaction
url http://www.mdpi.com/2076-0817/7/3/68
work_keys_str_mv AT sangimyun earlyeventsinjapaneseencephalitisvirusinfectionviralentry
AT youngminlee earlyeventsinjapaneseencephalitisvirusinfectionviralentry